Search

Severe acetaminophen (APAP)‐induced hepatic damage is the second most common cause for hepatic transplantation. Clinically, hepatic damage caused by APAP is treated using N‐acetyl‐L‐cysteine, which can induce numerous side effects. Naringin, a bioflavonoid abundant in grapefruit and other citrus fruits, displays marked antiinflammatory and antioxidant activities. Herein, we aimed to investigate the potential mechanism underlying naringin‐mediated protection against APAP‐induced acute hepatotoxicity. We observed that naringin afforded protection against APAP‐induced acute liver failure in mice. Importantly, pretreatment with naringin before APAP administration further increased antioxidant enzyme expression, inhibited the production of proinflammatory cytokines, and activated apoptotic pathways. Furthermore, we observed that the protective effect was associated with the upregulation of cation transport regulator‐like protein 2 (CHAC2) and nuclear factor erythroid derived‐2‐related factor 2 (Nrf2). Notably, CHAC2 knockdown inhibited Nrf2 activation and naringin‐mediated antioxidant, antiinflammatory, and antiapoptotic effects in APAP‐induced liver injury. Likewise, si‐Nrf2 blocked the protective effect of naringin against APAP‐induced liver injury. Collectively, our results indicate that naringin may be a potent CHAC2 activator, alleviating APAP‐induced hepatitis via CHAC2‐mediated activation of the Nrf2 pathway. These data provide new insights into mechanisms through which CHAC2 regulates APAP‐induced liver injury by targeting Nrf2, which should be considered a novel therapeutic target. [ABSTRACT FROM AUTHOR]